FDA Approves Cancer Drug That Doubles Eligible Patients

A new prostate cancer treatment just became available to nearly twice as many patients, offering hope earlier in their journey.

The FDA approved Pluvicto for men newly diagnosed with metastatic disease, marking a shift toward precision medicine from day one.